Siddharth Poddar
One large PIPE deal accounted for the lion’s share of private equity investment in the country, while fundraising figures underline the Chinese government’s 'robust support' for the asset class.
One large PIPE deal accounted for the lion’s share of private equity investment in the country, while fundraising figures underline the Chinese government’s 'robust support' for the asset class.
One large PIPE deal accounted for the lion’s share of private equity investment in the country, while fundraising figures underline the Chinese government’s 'robust support' for the asset class.
One large PIPE deal accounted for the lion’s share of private equity investment in the country, while fundraising figures underline the Chinese government’s 'robust support' for the asset class.
The Indian private equity firm has sold its controlling stake in Ventex to Pfizer Animal Health, reportedly for about $75m.
The Indian private equity firm has sold its controlling stake in Ventex to Pfizer Animal Health, reportedly for about $75m.
The Indian private equity firm has sold its controlling stake in Ventex to Pfizer Animal Health, reportedly for about $75m.
The Indian private equity firm has sold its controlling stake in Ventex to Pfizer Animal Health, reportedly for about $75m.
In its first cleantech deal, the Mumbai private equity firm has backed a company focused on the operation of biomass and small hydropower projects.
The Carlyle Group has reportedly submitted a bid for Asciano. Other private equity firms to have submitted bids include TPG and GIP, which have been trying to buy the Australian transport infrastructure company since last year.